Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

10-14 Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
25/08/26	€0.6300	-1.56%	41,059
24/08/26	€0.6400	-1.08%	113,610
21/08/26	€0.6470	-1.67%	23,754
20/08/26	€0.6580	+0.46%	6,861
19/08/26	€0.6550	+2.34%	29,661

Real-time Euronext Paris

More quotes

Annual profits - Rate of surprise

Company calendar

Real-time Euronext Paris 15:50:36 25/08/2026 +04			5-day change	1st Jan Change
0.6300 ^EUR	-1.56%		-1.56%	+4.65%

07-24	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
07-09	Theraclion Announces Board Changes	CI

Market Cap	46.79M 54.6M 43.77M 40.02M 75.52M 5.23B 76.32M 518M 201M 2.63B 205M 201M 8.69B	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	54.64M 63.76M 51.12M 46.73M 88.19M 6.11B 89.13M 605M 235M 3.07B 239M 234M 10.14B	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	39.01%	Yield 2024 *	-	Yield 2025	-

07-24	Theraclion SA Reports Consolidated Revenue Results for the First Half Ended June 30, 2026	CI
07-09	Theraclion Announces Board Changes	CI
07-09	Theraclion Appoints New Chairman	MT
06-19	Claude Lenoir appointed interim chairman of Theraclion
06-19	Theraclion Chairman Steps Down; Interim Successor Named	MT
06-18	Theraclion Announces Board Changes	CI
06-08	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
06-05	Theraclion deploys first Sonovein system in China
06-05	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
06-04	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
06-04	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
06-01	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
05-11	Bouygues, Euronext, Vallourec... stocks to watch today in Paris

07-23	Theraclion Initiates Its Commercial Momentum in the First Half of 2026	BU
07-15	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
07-09	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
06-18	Theraclion Announces the Evolution of Its Board of Directors	BU
06-08	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU

Theraclion Stock

Stocks

ALTHE

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

07-23	THERACLION AMORCE SA DYNAMIQUE COMMERCIALE AU PREMIER SEMESTRE 2026
07-15	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
07-09	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
07-09	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
06-19	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer

1 day	-1.56%
1 week	-1.56%
Current month	+8.43%
1 month	+6.24%
3 months	+27.40%
6 months	+3.28%
Current year	+4.65%

1 week	0.62	0.68
1 month	0.54	0.71
Current year	0.4	0.93
1 year	0.4	1.25
3 years	0.14	1.25
5 years	0.14	2.22
10 years	0.14	6.48

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Mehdi El Glaoui BRD	Director/Board Member	-	22/06/2021
Cédric Bellanger BRD	Director/Board Member	-	28/01/2022
Lijuan Deng BRD	Director/Board Member	-	29/06/2023

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	-1.56%	-1.56%	-27.59%	+2.94%	54.6M
THERMO FISHER SCIENTIFIC, INC.	-0.08%	+7.38%	+25.75%	+16.86%	232B
DANAHER CORPORATION	-1.71%	+6.16%	+1.56%	-15.16%	151B
INTUITIVE SURGICAL, INC.	-1.38%	-4.29%	-21.55%	+30.78%	132B
BOSTON SCIENTIFIC CORPORATION	-2.70%	-4.71%	-53.84%	-2.82%	71.03B
SIEMENS HEALTHINEERS AG	-1.15%	+1.17%	-16.03%	-12.13%	52.46B
EDWARDS LIFESCIENCES CORPORATION	+0.79%	-0.34%	+10.60%	+20.65%	52.16B
AGILENT TECHNOLOGIES, INC.	-3.50%	+3.35%	+26.14%	+28.40%	43.33B
WATERS CORPORATION	+0.01%	+0.74%	+35.92%	+51.47%	40.36B
GE HEALTHCARE TECHNOLOGIES INC.	-0.84%	+2.51%	-1.37%	+8.42%	33.51B
Average	-0.62%	+1.32%	-2.04%	+12.94%	80.86B
Weighted average by Cap.	-0.38%	+2.78%	+2.23%	+11.78%

	2024	2025
Net sales	830K 969K 777K 710K 1.34M 92.76M 1.35M 9.19M 3.57M 46.58M 3.64M 3.56M 154M	652K 761K 610K 558K 1.05M 72.85M 1.06M 7.22M 2.81M 36.58M 2.86M 2.79M 121M
Net income	-5.76M -6.72M -5.39M -4.92M -9.29M -643M -9.39M -63.73M -24.78M -323M -25.22M -24.68M -1.07B	-5.69M -6.64M -5.32M -4.87M -9.18M -636M -9.28M -62.99M -24.49M -319M -24.93M -24.39M -1.06B
Net Debt	3.41M 3.98M 3.19M 2.92M 5.5M 381M 5.56M 37.76M 14.68M 191M 14.94M 14.62M 633M	7.85M 9.16M 7.35M 6.72M 12.67M 877M 12.81M 86.92M 33.8M 441M 34.4M 33.66M 1.46B